SEC Filings

Filing date	Form	Description	View
04/24/15	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-15-030157.pdf 0001104659-15-030157.rtf 0001104659-15-030157.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006594.pdf 0001179110-15-006594.rtf 0001179110-15-006594.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006595.pdf 0001179110-15-006595.rtf 0001179110-15-006595.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006596.pdf 0001179110-15-006596.rtf 0001179110-15-006596.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006600.pdf 0001179110-15-006600.rtf 0001179110-15-006600.xls
04/24/15	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-15-006599.pdf 0001179110-15-006599.rtf 0001179110-15-006599.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006598.pdf 0001179110-15-006598.rtf 0001179110-15-006598.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006597.pdf 0001179110-15-006597.rtf 0001179110-15-006597.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006603.pdf 0001179110-15-006603.rtf 0001179110-15-006603.xls
04/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-006602.pdf 0001179110-15-006602.rtf 0001179110-15-006602.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.